NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

Not sure where that $50MM comes from, but let’s just say it’s true. You’re making the case for either a pending buyout or a JV with a significant upfront payment.

The fact (and these are facts) that management has done very little in terms of preparing the company to uplist or remain independent speaks for itself.

Here's the problem: If TLD is positive, they need to raise a significant amount of money in anticipation of pursuing regulatory approvals and commercialization (around $50 million?). But I don't see how they can do that without either increasing the amount of shares that are authorized for further issuance or doing a reverse split to bring the number under the current authorization.